跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
REXXOLIDE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
REXXOLIDE
Authorized
STANDARD
REXXOLIDE
DECHRA REGULATORY BV
🇨🇦 Health Canada
Approval Date
Feb 5, 2026
Approval ID
473f1ba1415721d1
Company
DECHRA REGULATORY BV
Type
Standard
Approval Details
Approval Id
473f1ba1415721d1
Drug Approval Canada Name
REXXOLIDE
Product Name
REXXOLIDE
Status
Marketed
Status Date
2022-02-24
Original Market Date
2022-02-24
Drug Class
Veterinary
Dosage Form
Solution
Route Of Administration
Subcutaneous , Intramuscular
Schedule
Prescription
Atc Original
Not Applicable
Aig Number
0151667001
Company Name
DECHRA REGULATORY BV
Company Address
Handelsweg 25 Bladel -- Netherlands 5531 AE
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Feb 5, 2026
Approval ID
473f1ba1415721d1
Type
Standard
Back to Health Canada Approvals